Piogomet-G1 – Triple Action Diabetes Control
Piogomet-G1 by Aseric Pharma is a combination tablet of Glimepiride, Pioglitazone & Metformin HCl, formulated for effective management of type 2 diabetes mellitus. This triple-action therapy helps improve insulin sensitivity, enhance glucose utilization, and control blood sugar levels. Manufactured in GMP-WHO certified facilities, Piogomet-G1 ensures consistent quality, safety, and reliable therapeutic outcomes for long-term diabetes care.